Short-Term Outcomes of 3 Monthly intravitreal Faricimab On Different Subtypes of Neovascular Age-Related Macular Degeneration-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Short-Term Outcomes of 3 Monthly intravitreal Faricimab On Different Subtypes of Neovascular Age-Related Macular Degeneration

Published:2024-02 Issue: Volume:Volume 18 Page:507-516
ISSN:1177-5483
Container-title:Clinical Ophthalmology
language:en
Short-container-title:OPTH

Author:

Tanaka Asako,Hata Masayuki,Tsuchikawa Memiri,Ueda-Arakawa Naoko,Tamura Hiroshi^ORCID,Miyata Manabu,Takahashi Ayako,Kido Ai,Muraoka Yuki^ORCID,Miyake Masahiro,Ooto Sotaro,Tsujikawa Akitaka^ORCID

Publisher

Informa UK Limited

Reference32 articles.

1. Managed care opportunities and approaches to select treatment for sight preservation

2. Ranibizumab for Neovascular Age-Related Macular Degeneration

3. Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration

4. Non-responders to treatment with antagonists of vascular endothelial growth factor in age-related macular degeneration

5. Non-responsiveness to intravitreal aflibercept treatment in neovascular age-related macular degeneration: implications of serous pigment epithelial detachment

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Three-month outcomes of treatment with faricimab or aflibercept for neovascular age-related macular degeneration: a propensity score matching study in a Japanese population;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-07-29

2. Real-world efficacy of intravitreal faricimab for neovascular age-related macular degeneration: a systematic review;International Journal of Retina and Vitreous;2024-07-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP